fda compounding semaglutide update alerts health care providers, compounders and patients of dosing errors associated with compounded injectable products The FDA's Decision to Ban

11 lbs Average Weight Loss over 12 weeks, with individual participant transformations reaching up to 25 lbs

These types of medications mimic a hormone that takes on many tasks such as stimulating insulin production, signaling the brain to produce hunger cues, and helping control how quickly food passes through the stomach

Additionally, alcohol can impair awareness of hypoglycemic symptoms, making it more difficult for patients to recognize and respond to low blood sugar

Heallys platform simplifies the process of connecting with a specialized weight loss doctor who can tailor your treatment plan to your unique needs

First developed for diabetes, drugs such as semaglutide and tirzepatide regulate blood sugar, suppress appetite and induce satiety

All medications are HSA/FSA eligible, making treatment accessible to uninsured and underinsured patients across all 50 states